Your Thyroid Numbers Look Normal, But You Still Feel Exhausted.

Deiodinase type 2 (DIO2) is the enzyme responsible for converting inactive T4 into active T3. This conversion happens in your liver, kidneys, gut, brain, and muscle tissue, not just in your thyroid. It’s one of the most important steps in thyroid metabolism.

The DIO2 Thr92Ala variant, particularly the Ala/Ala genotype, is present in roughly 12-15% of people with European ancestry. If you carry this variant, your cells convert T4 to T3 less efficiently than someone without it, sometimes by 20-30% or more. This means that even with a normal T4 level, you may not be producing enough T3 at the tissue level.

Here’s what this feels like: fatigue that doesn’t respond to rest, cold hands and feet, weight gain despite normal calorie intake, and a persistent fogginess that makes concentration difficult. You might feel better on a T3-containing medication or supplement, even though standard dosing would suggest you don’t need it. Your thyroid is functioning, but your tissues aren’t getting enough active hormone.

Thyroid peroxidase (TPO) is the enzyme your thyroid gland uses to manufacture thyroid hormones in the first place. Without TPO functioning correctly, your thyroid can’t produce enough T3 and T4, regardless of how much iodine or selenium you consume.

TPO variants, present in roughly 20-30% of the population, are strongly associated with Hashimoto’s thyroiditis and increased hypothyroidism susceptibility. Certain TPO variants increase your risk of your immune system attacking your thyroid cells, or directly impair the enzyme’s ability to synthesize hormones. This can happen even when TSH is still normal, before your thyroid has been damaged enough to raise TSH significantly.

You might experience slowly declining energy, increasing sensitivity to cold, and gradual weight gain over months. Your thyroid antibodies might be elevated (TPO and thyroglobulin), or they might not be yet. But the gene is there, increasing your risk, and your thyroid is already struggling to produce enough hormone.

The TSH receptor (TSHR) sits on the surface of your thyroid cells and receives signals from your pituitary gland to produce more thyroid hormone. How sensitive this receptor is determines how much hormone your thyroid will make in response to a given TSH level.

TSHR variants are present in roughly 10-20% of people and are associated with Graves’ disease and with shifts in what’s considered a normal TSH range for you personally. If you carry a TSHR variant that reduces receptor sensitivity, your thyroid may require a higher TSH signal to produce the same amount of hormone that someone without the variant produces at a lower TSH. This means your TSH might look normal while your actual thyroid output is below what your tissues need.

You might notice that you feel better when TSH is on the lower end of normal, or that standard thyroid dosing leaves you still feeling hypothyroid. Your thyroid is receiving the signal, but the receptor isn’t responding robustly enough, so hormone production stays low.

MTHFR catalyzes methylation, a fundamental cellular process that happens billions of times per day in your body. Thyroid hormone metabolism depends on methylation. So does the regulation of thyroid antibodies, and the function of selenium-dependent thyroid enzymes like glutathione peroxidase and thioredoxin reductase.

The MTHFR C677T variant is present in roughly 40% of people with European ancestry. If you’re homozygous (two copies), your methylation capacity is reduced by 35-40%, which directly impacts your thyroid’s ability to regulate immune function and maintain enzymatic cofactor availability. This means your thyroid is more vulnerable to immune attack, and your thyroid enzymes are less efficient.

You might have elevated thyroid antibodies, or you might notice that standard thyroid treatment doesn’t resolve your symptoms. You might also struggle with other methylation-dependent processes, like detoxification or neurotransmitter balance, which makes thyroid problems feel even more entrenched.

The vitamin D receptor (VDR) controls how your cells respond to vitamin D, a hormone that powerfully regulates immune tolerance. Your thyroid is an immune-privileged organ, and maintaining immune tolerance depends partly on adequate vitamin D signaling through VDR.

VDR variants affect how efficiently your cells can bind and use vitamin D. If you carry certain VDR variants, you may need higher circulating vitamin D levels to achieve the same immune-regulatory effect as someone without the variant. This is particularly important for thyroid health, since reduced immune tolerance increases thyroid antibody attacks.

You might have normal vitamin D lab values but still experience worsening thyroid antibodies, or you might notice that supplementing vitamin D doesn’t seem to help with autoimmune thyroid symptoms. Your cells simply aren’t responding to the vitamin D signal as robustly as they should be.

COMT (catechol-O-methyltransferase) clears stress hormones like epinephrine and norepinephrine. When COMT is slow, these hormones build up, keeping your nervous system in a chronic fight-or-flight state. Over time, chronic HPA axis activation suppresses TSH and thyroid hormone production as your body down-regulates metabolism during perceived chronic threat.

The COMT Val158Met slow variant is present in roughly 25% of people homozygously in European ancestry. If you have slow COMT, your stress hormones clear slowly, your nervous system stays elevated, and your thyroid output gets suppressed as a result. Even if your TPO, DIO2, and TSHR are all functioning normally, chronic stress-hormone elevation can still impair thyroid production.

You might notice that your thyroid symptoms worsen during stressful periods, or that your energy and temperature regulation improve dramatically when you reduce stress. You might also feel wired, struggle with caffeine sensitivity, and have a hard time unwinding even when you’re physically exhausted.